Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Circulating Tumor DNA Detection in Surveillance for Stage ⅢA Non-small-cell Lung Cancer Patients

NCT02696525 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT02696525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02696525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Circulating Tumor DNA Detection in Surveillance for Stage ⅢA Non-small-cell Lung Cancer Patients
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2018
Completion date
December 31, 2021
Enrollment
145 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, lung neoplasms, non-small-cell lung cancer